FINWIRES · TerminalLIVE
FINWIRES

Westpac Banking Flags Decline in Average Monthly Mortgage Application Volumes; Shares Down 4%

By

Westpac Banking (ASX:WBC, NZE:WBC) said its average monthly mortgage applications fell 20% between May 15 and the end of July following the Australian government's changes to property tax policy, according to a Monday filing with the Australian bourse.

The bank's average monthly volume of mortgage applications declined 11% from the fiscal second quarter to hit 29,000 in the fiscal third quarter.

Westpac expects housing credit growth to moderate to 4.7% in fiscal 2027 from 6.8% fiscal 2026 before recovering to 5.2% in fiscal 2028, per the filing.

The company also flagged a marginal slowdown in consumer spending since the eruption of the Middle East conflict.

Westpac's Australian and New Zealand shares each fell nearly 4% in recent Monday trade.

Related Articles

Asia

Aspial Lifestyle's H1 Attributable Profit Surges 88%

Aspial Lifestyle's (SGX:5UF) recorded an 88% rise in attributable profit in the first half of 2026 to SG$52.4 million from SG$27.9 million a year prior.Earnings per share stood at SG$0.0277, up from SG$0.015 previously, according to a Friday filing with the Singapore bourse.Revenue jumped 26% to SG$464.2 million from SG$367.2 million in the year-ago period.

SGX:5UF
Asia

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group's Benmelstobart Injection obtained marketing approval from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug in combination with chemotherapy and sequentially followed by Anlotinib Hydrochloride Capsules for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.

HKG:1177
Asia

Lygend Resources Gets CSRC Nod for China Listed-Share IPO

Lygend Resources & Technology (HKG:2245) obtained approval for its registration application related to its China listed-share initial public offering from the China Securities Regulatory Commission (CSRC).The share offering is subject to various conditions, including certain final regulatory approvals, according to a Friday Hong Kong bourse filing.

HKG:2245